Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$27,875,239
+$2,596,966 QoQ
Shares Held
109,758
+6.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#621
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ethic Inc. holds $332,739,634 across 14 Drug Manufacturers - General names. JNJ ranks #3 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
90,920 | $109,052,184 | |
| 2 | MRK |
Merck & Co., Inc.
|
358,041 | $46,008,268 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
109,758 | $27,875,239 | |
| 4 | PFE |
Pfizer Inc
|
882,175 | $21,242,774 | |
| 5 | ABBV |
AbbVie Inc.
|
83,563 | $21,027,793 | |
| 6 | AMGN |
Amgen Inc
|
56,184 | $20,345,350 | |
| 7 | NVS |
Novartis AG
|
108,784 | $17,048,628 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
270,904 | $15,609,488 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,875,239 | 109,758 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $25,278,273 | 103,413 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $17,194,233 | 83,084 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $15,471,444 | 83,440 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $9,142,851 | 59,855 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $9,126,506 | 55,032 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $14,458,962 | 99,979 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,341,103 | 82,322 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $11,307,668 | 77,365 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $13,022,517 | 82,322 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,889,189 | 24,813 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,684,181 | 30,075 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,026,274 | 24,325 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,435,575 | 22,165 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,112,058 | 23,278 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,025,843 | 24,644 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,393,017 | 24,748 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $2,459,775 | 13,879 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,793,819 | 22,177 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,127,770 | 19,367 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,460,062 | 14,933 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,431,159 | 8,708 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,197,339 | 13,962 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,561,182 | 17,203 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $233,586 | 1,661 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $473,248 | 3,609 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||